252
Views
4
CrossRef citations to date
0
Altmetric
GnRH Antagonist does not prevent premature luteinization

GnRH antagonist does not prevent premature luteinization and ovulation in stimulated cycles with gonadotropins for IVF: two case reports

, , , &
Pages 189-191 | Received 04 Apr 2017, Accepted 12 Sep 2017, Published online: 23 Sep 2017

References

  • Boim G, Mannaerts B. The European Orgalutran Study Group. Treatment with the gonadotropin releasing-hormone antagonist ganirelix in womwn undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient results of a controlled, randomized, multicentre trial. Hum Reprod 2000;15:1490–8.
  • Itskovits-Eldor J, Kol S, Mannaerts B. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report, short comunication. Hum Reprod 2000;15:1965–8.
  • Ludwing M, Felberbaum RE, Devroey P, et al. Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction. Arch Gynecol Obstet 2000;264:29–32.
  • Reichman DE, Zakarin L, Chao K, et al. Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surge in vitro fetilizzayion cycles. Fertil Steril 2014;102:99–102.
  • Bosch E, Valencia I, Escudero E, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril 2003;80:1444–9.
  • Shao-Ying WU F, Kuo-Kuang Lee R, Hwu YM. Encountering premature ovulation during controlled ovarian hyperstimulation in IVF/ICSI cycles. Taiwan Journ of Obstet and Gynecol 2012;51:256–9.
  • Younis JS, Matilsky M, Radin O, Ben-Ami M. Increased progesteron/estradiol ratio in the late follicular phase could be related to low ovarian reserve in vitro fertilization-embrio tranfer cycle with a long gonadotropin releasing hormone agonist. Fertil Steril 2001;76:294–9.
  • Younis JS, Haddad S, Matilsky M, Ben-Ami M. Premature luteinization: could it be an early manifestation of low ovarian reserve? Fertil Steril 1998;69:461–5.
  • Sonmezer M, Pelin Cil A, Atabekoglu C, et al. Does premature luteinization or early surge of LH impair cycle outcome? Report of two successful outcomes. J Assist Reprod Genet 2009;26:159–63.
  • Lawrenz B, Beligotti F, Engelmann N, et al. Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles. Hum Reprod 2016;31:2554–60.
  • Tarlatzis BC, Fauser BC, Kolibianakis EM, et al. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod 2006;12:333–40.
  • Messinis IE, Vanakara P, Zavos A, et al. Failure of GnRH antagonist Ganirelix to block the positive feedback effect of exogenous estrogen in normal women. Fertil Steril 2010;94:1554–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.